UBS Group’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-20,385
| Closed | -$26K | – | 9171 |
|
|
2023
Q3 | $26K | Sell |
20,385
-6,183
| -23% | -$7.88K | ﹤0.01% | 5533 |
|
|
2023
Q2 | $8.66K | Sell |
26,568
-3,718
| -12% | -$1.21K | ﹤0.01% | 6143 |
|
|
2023
Q1 | $13K | Sell |
30,286
-11,734
| -28% | -$5.05K | ﹤0.01% | 6327 |
|
|
2022
Q4 | $22.3K | Buy |
42,020
+15,130
| +56% | +$8.02K | ﹤0.01% | 6366 |
|
|
2022
Q3 | $20K | Buy |
26,890
+1,988
| +8% | +$1.48K | ﹤0.01% | 6343 |
|
|
2022
Q2 | $28K | Sell |
24,902
-2,719
| -10% | -$3.06K | ﹤0.01% | 5460 |
|
|
2022
Q1 | $56K | Buy |
27,621
+16,357
| +145% | +$33.2K | ﹤0.01% | 5372 |
|
|
2021
Q4 | $32K | Buy |
11,264
+5,494
| +95% | +$15.6K | ﹤0.01% | 6232 |
|
|
2021
Q3 | $25K | Sell |
5,770
-7,052
| -55% | -$30.6K | ﹤0.01% | 5810 |
|
|
2021
Q2 | $68K | Buy |
12,822
+8,319
| +185% | +$44.1K | ﹤0.01% | 5116 |
|
|
2021
Q1 | $21K | Sell |
4,503
-2,726
| -38% | -$12.7K | ﹤0.01% | 6334 |
|
|
2020
Q4 | $23K | Buy |
7,229
+1,483
| +26% | +$4.72K | ﹤0.01% | 5841 |
|
|
2020
Q3 | $20K | Buy |
5,746
+4,515
| +367% | +$15.7K | ﹤0.01% | 5451 |
|
|
2020
Q2 | $5K | Sell |
1,231
-16,849
| -93% | -$68.4K | ﹤0.01% | 6542 |
|
|
2020
Q1 | $69K | Sell |
18,080
-19,515
| -52% | -$74.5K | ﹤0.01% | 4704 |
|
|
2019
Q4 | $227K | Buy |
37,595
+2,642
| +8% | +$16K | ﹤0.01% | 4527 |
|
|
2019
Q3 | $264K | Sell |
34,953
-11,892
| -25% | -$89.8K | ﹤0.01% | 4163 |
|
|
2019
Q2 | $635K | Buy |
46,845
+39,121
| +506% | +$530K | ﹤0.01% | 3379 |
|
|
2019
Q1 | $42K | Sell |
7,724
-4,847
| -39% | -$26.4K | ﹤0.01% | 4878 |
|
|
2018
Q4 | $38K | Buy |
12,571
+6,990
| +125% | +$21.1K | ﹤0.01% | 5416 |
|
|
2018
Q3 | $46K | Buy |
5,581
+373
| +7% | +$3.07K | ﹤0.01% | 5336 |
|
|
2018
Q2 | $50K | Sell |
5,208
-2,225
| -30% | -$21.4K | ﹤0.01% | 5068 |
|
|
2018
Q1 | $64K | Sell |
7,433
-309
| -4% | -$2.66K | ﹤0.01% | 4697 |
|
|
2017
Q4 | $97K | Sell |
7,742
-2,493
| -24% | -$31.2K | ﹤0.01% | 4444 |
|
|
2017
Q3 | $86K | Sell |
10,235
-4,119
| -29% | -$34.6K | ﹤0.01% | 4530 |
|
|
2017
Q2 | $244K | Buy |
14,354
+10,457
| +268% | +$178K | ﹤0.01% | 3791 |
|
|
2017
Q1 | $78K | Sell |
3,897
-932
| -19% | -$18.7K | ﹤0.01% | 4347 |
|
|
2016
Q4 | $75K | Buy |
4,829
+3,829
| +383% | +$59.5K | ﹤0.01% | 4607 |
|
|
2016
Q3 | $13K | Buy |
+1,000
| New | +$13K | ﹤0.01% | 5706 |
|
|
2016
Q1 | – | Sell |
-4,311
| Closed | -$43K | – | 6938 |
|
|
2015
Q4 | $43K | Buy |
4,311
+2,482
| +136% | +$24.8K | ﹤0.01% | 4862 |
|
|
2015
Q3 | $27K | Buy |
+1,829
| New | +$27K | ﹤0.01% | 5207 |
|